Patient Access to Innovative New Technologies Act of 2024
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Patient Access to Innovative New Technologies Act of 2024 is a House bill introduced in the 118th Congress aimed at improving patient access to new medical technologies. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and appears intended to address regulatory or access barriers to innovative health technologies.
This bill sought to enhance patient access to innovative medical technologies but did not progress beyond subcommittee referral and is now expired.
- Introduced in the House during the 118th Congress as H.R. 7939.
- Focused on health policy, specifically patient access to new medical technologies.
- Referred to the Subcommittee on Health on December 17, 2024, with no further legislative action.
['Patients seeking access to innovative medical technologies', 'Healthcare providers involved in delivering new technologies', 'Medical technology developers and manufacturers']
['Lack of available full text and official summary limits understanding of specific provisions and implementation requirements.', 'Unclear funding mechanisms or regulatory changes that might be required.', 'Potential oversight and enforcement challenges given no detailed legislative language is available.']
The bill was introduced in the House and referred to the Subcommittee on Health but did not advance further, resulting in its failure or expiration. This indicates limited legislative momentum or prioritization within the 118th Congress. The health policy area often involves complex regulatory and stakeholder considerations, which may have influenced the bill's progress.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased demand on healthcare providers and regulatory agencies if the bill had passed, due to new technologies requiring integration into care.', 'Possible stimulation of innovation incentives for medical technology developers if access barriers were reduced.', 'Uncertain fiscal impacts on federal health programs depending on the nature of access improvements.']
The absence of an official summary and full bill text restricts transparency and public understanding of the bill's specific provisions and potential impacts. The bill's failure to advance beyond subcommittee referral suggests limited legislative engagement or prioritization. Future proposals on similar topics would benefit from clear, accessible documentation to facilitate oversight and informed public discourse.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.